Dako A/S
DK-2600 Glostrup, Denmark (Map) Phone: +45-44-85-95-00
Fax: +45-44-85-95-95
Primary US Office:
Subscribers Only http://www.dako.com
Overview
Dako makes disease diagnosis a little more clear-cut. A leader in the area of pathology testing, Dako makes instrumentation systems, reagents, and software used by pathology laboratories to analyze human tissues for the presence of cancer. Its Automated Link line of pathology instruments include staining and visualization systems, chemical and antibody reagents, and Dako Link workflow management software. The company also makes reagents used in flow cytometry testing (which analyzes the cells in blood) and in clinical immunochemistry (which measures proteins in body fluids). The company was acquired by private equity fund EQT in 2007 and subsequently divested its flow cytometry instrumentation business.
Sample OverviewKey Numbers from Hoover's UK
Key financials for Dako A/S
| Company Type | Private |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Dako A/S
| President and CEO | Patrik Dahlén (Subscribers see complete biographies -- view sample)
|
|---|---|
| CFO | Per Toelstang |
| Corporate VP Human Resources | Jørgen Andersen |
Top Competitors from Hoover's UK
Top competitors of Dako A/S
There are 8 competitors for Dako; see more.
